We are live on ! Find out more
ATYR

aTyr Pharma

29 hedge funds and large institutions have $33.8M invested in aTyr Pharma in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more call options, than puts

Call options by funds: $96K | Put options by funds: $12K

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

120% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 5

28% more capital invested

Capital invested by funds: $26.3M → $33.8M (+$7.45M)

16% more funds holding

Funds holding: 2529 (+4)

6.14% more ownership

Funds ownership: 36.92%43.05% (+6.1%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
29
Holders Change
+4
Holders Change %
+16%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
11
Reduced
5
Closed
3
Calls
$96K
Puts
$12K
Net Calls
+$84K
Net Calls Change
+$84K
Name Holding Trade Value Shares
Change
Change in
Stake
SWM
26
Spire Wealth Management
Virginia
-$63K -14,000 Closed
ECM
27
ExodusPoint Capital Management
New York
-$49K -11,066 Closed
IF
28
Ironwood Financial
Arizona
-$26 -6 -11%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
+$4 +1 New
Wells Fargo
30
Wells Fargo
California
+$149 +35 +56%

ATYR Hedge Fund Activity: Q2 2021 in Review

29 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in aTyr Pharma (ATYR) for Q2 2021, worth a combined $33.8M — up 28% from $26.3M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ATYR positions and 3 closed out — a net gain of 4 holders — while 11 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.28M. The largest seller was Renaissance Technologies, cutting an estimated $280K.

  • 29 institutional investors held aTyr Pharma (ATYR) as of Q2 2021, up from 25 in Q1 2021.
  • Funds reported $33.8M of aTyr Pharma stock for Q2 2021, up 28% quarter-over-quarter.
  • 7 funds opened new aTyr Pharma positions in Q2 2021 and 3 closed out, a net change of +4 holders.
  • The largest aTyr Pharma buyer in Q2 2021 was Vanguard Group, an estimated $1.28M added.
  • The largest aTyr Pharma seller in Q2 2021 was Renaissance Technologies, an estimated $280K sold.

Based on aggregated 13F filings for Q2 2021.